Ying Wang
- Role
- Research Fellow Head of Act Group at AbbVie
- Location
- Libertyville, IL, US
- LinkedIn followers
- 500 followers
About Ying Wang
Head of Advanced Chemistry Technologies (ACT) group at AbbVie -led and established ACT as…
Experience
Research Fellow Head of Act Group
Nov 2014 — Present
Led Advanced Chemistry Technologies (ACT) group since 2014, an industry leading chemistry technology group specializes in automated parallel library synthesis, high throughput experimentation (HTE), Late -Stage Functionalization (LSF), and a suite of enabling chemistry technologies (photoredox, flow, biocatalysis, and high pressure chemistry) for med chem research. Built Late-Stage Functionalization (LSF) capability for lead compound diversification at AbbVie Initiated and established HTE function within AbbVie Discovery by leveraging proprietary ChemBeads technology (co-inventor) in 2017. Championed the first wave of machine learning (ML) in chemistry projects (2019); proposed and chaired cross-function ML in Chemistry working group; advocated and pioneered the work on the integration of ML on med chem research utilizing internal chemistry data sets. Led the efforts and set strategies on enhancing corporate building block collection accessibility, searchability, and synthesis; Chair of the Strategic Monomer initiative at AbbVie and AbbVie representative on precompetitive BBXC (Building Block Exchange Consortium).
Skills
- Medicinal Chemistry
- Neuroscience
- Laboratory
- Drug Development
- Oncology
- CRO
- Chromatography
- Lc-Ms
- Organic Synthesis
- Chemistry
- Organic Chemistry
- Drug Design
- High Throughput Screening
- Hplc
- Drug Discovery
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.